meitshel

CMRX nice bottom play very good risk reward ratio

Long
meitshel Updated   
NASDAQ:CMRX   Chimerix, Inc.
i like this set up due to risk reward ratio

09/23/2018
Phase 1 data due 23-26 September 2018 at European Society for Clinical Virology.
Trade closed: stop reached
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.